charles shepherd
Senior Member
- Messages
- 2,239
Phase 3 trial of duloxetine/Cymbalta for fibromyalgic pain may show benefit for some patients with ME/CFS | 27 August 2015
The results of a phase 3, Japanese trial of duloxetine/Cymbalta for pain in patients with Fibromyalgia have been published in the journal Arthritis Research and Therapy. Our medical adviser, DR CHARLES SHEPHERD, says that – while the results were not hugely significant – they may point to benefits for some people with ME/CFS.
Duloxetine (trade name = Cymbalta) is a drug that is normally used to treat depression. It is sometimes used for a generalised anxiety disorder and for stress incontinence.
It acts by normalising an imbalance in two brain chemical transmitters – noradrenaline and serotonin – that can occur in depression.
continued on MEA website>>
http://www.meassociation.org.uk/201...-for-some-patients-with-mecfs-27-august-2015/
The results of a phase 3, Japanese trial of duloxetine/Cymbalta for pain in patients with Fibromyalgia have been published in the journal Arthritis Research and Therapy. Our medical adviser, DR CHARLES SHEPHERD, says that – while the results were not hugely significant – they may point to benefits for some people with ME/CFS.
Duloxetine (trade name = Cymbalta) is a drug that is normally used to treat depression. It is sometimes used for a generalised anxiety disorder and for stress incontinence.
It acts by normalising an imbalance in two brain chemical transmitters – noradrenaline and serotonin – that can occur in depression.
continued on MEA website>>
http://www.meassociation.org.uk/201...-for-some-patients-with-mecfs-27-august-2015/